PharmaShots | Incisive News in 3 Shots

Subscribe Now

inflammatory

Cardinal Health Reports the Discontinuation of Biosimilar Infliximab & Switched Back to Remicade in the VA Study for Inflammatory Conditions

Cardinal Health Reports the Discontinuation of Biosimilar Infliximab & Switched Back to Remicade in the VA Study for Inflammatory...

February 12, 2022

Bayer's Finerenone Demonstrates Positive Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes

Bayer's Finerenone Demonstrates Positive Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes

November 18, 2020

Pfizer's Amsparity (biosimilar- adalimumab) Receives CHMP's Positive Opinion for Inflammatory and Autoimmune Disorders

Pfizer's Amsparity (biosimilar- adalimumab) Receives CHMP's Positive Opinion for Inflammatory and Autoimmune Disorders

December 13, 2019

Genentech Acquires Jecure Therapeutics for its Preclinical Stage NLRP3 inhibitors

Genentech Acquires Jecure Therapeutics for its Preclinical Stage NLRP3 inhibitors

November 29, 2018

Sanofi and Denali Therapeutics Collaborates to Develop & Commercialize Clinical Candidates for Neurology and Inflammatory Disorders

Sanofi and Denali Therapeutics Collaborates to Develop & Commercialize Clinical Candidates for Neurology and Inflammatory Diso...

November 1, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us